These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18815813)

  • 1. Targeted delivery of therapeutics to endothelium.
    Simone E; Ding BS; Muzykantov V
    Cell Tissue Res; 2009 Jan; 335(1):283-300. PubMed ID: 18815813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting antioxidant and antithrombotic biotherapeutics to endothelium.
    Carnemolla R; Shuvaev VV; Muzykantov VR
    Semin Thromb Hemost; 2010 Apr; 36(3):332-42. PubMed ID: 20490983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced drug delivery systems that target the vascular endothelium.
    Ding BS; Dziubla T; Shuvaev VV; Muro S; Muzykantov VR
    Mol Interv; 2006 Apr; 6(2):98-112. PubMed ID: 16565472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial endocytic pathways: gates for vascular drug delivery.
    Muro S; Koval M; Muzykantov V
    Curr Vasc Pharmacol; 2004 Jul; 2(3):281-99. PubMed ID: 15320826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules.
    Muro S; Muzykantov VR
    Curr Pharm Des; 2005; 11(18):2383-401. PubMed ID: 16022673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting vascular inflammation through emerging methods and drug carriers.
    Nong J; Glassman PM; Muzykantov VR
    Adv Drug Deliv Rev; 2022 May; 184():114180. PubMed ID: 35271986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting therapeutics to endothelium: are we there yet?
    Kiseleva RY; Glassman PM; Greineder CF; Hood ED; Shuvaev VV; Muzykantov VR
    Drug Deliv Transl Res; 2018 Aug; 8(4):883-902. PubMed ID: 29282646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomedical aspects of targeted delivery of drugs to pulmonary endothelium.
    Muzykantov VR
    Expert Opin Drug Deliv; 2005 Sep; 2(5):909-26. PubMed ID: 16296786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted endothelial nanomedicine for common acute pathological conditions.
    Shuvaev VV; Brenner JS; Muzykantov VR
    J Control Release; 2015 Dec; 219():576-595. PubMed ID: 26435455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro characterization of leukocyte mimetic for targeting therapeutics to the endothelium using two receptors.
    Omolola Eniola A; Hammer DA
    Biomaterials; 2005 Dec; 26(34):7136-44. PubMed ID: 15953632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm.
    Howard M; Zern BJ; Anselmo AC; Shuvaev VV; Mitragotri S; Muzykantov V
    ACS Nano; 2014 May; 8(5):4100-32. PubMed ID: 24787360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic factors controlling targeting nanocarriers to vascular endothelium.
    Muzykantov VR; Radhakrishnan R; Eckmann DM
    Curr Drug Metab; 2012 Jan; 13(1):70-81. PubMed ID: 22292809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting delivery of drugs in the vascular system.
    Muzykantov V; Muro S
    Int J Transp Phenom; 2011; 12(1-2):41-49. PubMed ID: 25328360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug carriers for vascular drug delivery.
    Koren E; Torchilin VP
    IUBMB Life; 2011 Aug; 63(8):586-95. PubMed ID: 21766415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A newly synthesized sinapic acid derivative inhibits endothelial activation in vitro and in vivo.
    Zeng X; Zheng J; Fu C; Su H; Sun X; Zhang X; Hou Y; Zhu Y
    Mol Pharmacol; 2013 May; 83(5):1099-108. PubMed ID: 23470287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury.
    Kozower BD; Christofidou-Solomidou M; Sweitzer TD; Muro S; Buerk DG; Solomides CC; Albelda SM; Patterson GA; Muzykantov VR
    Nat Biotechnol; 2003 Apr; 21(4):392-8. PubMed ID: 12652312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endothelial dysfunction and metabolic effects of nitric oxide in human].
    Kolesnichenko OIu; Filatova LM; Krivitsina ZA; Voronkov IuI
    Fiziol Cheloveka; 2003; 29(5):74-81. PubMed ID: 14611088
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.
    Kim YG; Suga SI; Kang DH; Jefferson JA; Mazzali M; Gordon KL; Matsui K; Breiteneder-Geleff S; Shankland SJ; Hughes J; Kerjaschki D; Schreiner GF; Johnson RJ
    Kidney Int; 2000 Dec; 58(6):2390-9. PubMed ID: 11115072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.